TY - JOUR
T1 - Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
AU - Williams-Karnesky, Rebecca L.
AU - Sandau, Ursula S.
AU - Lusardi, Theresa A.
AU - Lytle, Nikki K.
AU - Farrell, Joseph M.
AU - Pritchard, Eleanor M.
AU - Kaplan, David L.
AU - Boison, Detlev
PY - 2013/8/1
Y1 - 2013/8/1
N2 - Epigenetic modifications, including changes in DNA methylation, lead to altered gene expression and thus may underlie epileptogenesis via induction of permanent changes in neuronal excitability. Therapies that could inhibit or reverse these changes may be highly effective in halting disease progression. Here we identify an epigenetic function of the brain's endogenous anticonvulsant adenosine, showing that this compound induces hypomethylation of DNA via biochemical interference with the transmethylation pathway. We show that inhibition of DNA methylation inhibited epileptogenesis in multiple seizure models. Using a rat model of temporal lobe epilepsy, we identified an increase in hippocampal DNA methylation, which correlates with increased DNA methyltransferase activity, disruption of adenosine homeostasis, and spontaneous recurrent seizures. Finally, we used bioengineered silk implants to deliver a defined dose of adenosine over 10 days to the brains of epileptic rats. This transient therapeutic intervention reversed the DNA hypermethylation seen in the epileptic brain, inhibited sprouting of mossy fibers in the hippocampus, and prevented the progression of epilepsy for at least 3 months. These data demonstrate that pathological changes in DNA methylation homeostasis may underlie epileptogenesis and reversal of these epigenetic changes with adenosine augmentation therapy may halt disease progression.
AB - Epigenetic modifications, including changes in DNA methylation, lead to altered gene expression and thus may underlie epileptogenesis via induction of permanent changes in neuronal excitability. Therapies that could inhibit or reverse these changes may be highly effective in halting disease progression. Here we identify an epigenetic function of the brain's endogenous anticonvulsant adenosine, showing that this compound induces hypomethylation of DNA via biochemical interference with the transmethylation pathway. We show that inhibition of DNA methylation inhibited epileptogenesis in multiple seizure models. Using a rat model of temporal lobe epilepsy, we identified an increase in hippocampal DNA methylation, which correlates with increased DNA methyltransferase activity, disruption of adenosine homeostasis, and spontaneous recurrent seizures. Finally, we used bioengineered silk implants to deliver a defined dose of adenosine over 10 days to the brains of epileptic rats. This transient therapeutic intervention reversed the DNA hypermethylation seen in the epileptic brain, inhibited sprouting of mossy fibers in the hippocampus, and prevented the progression of epilepsy for at least 3 months. These data demonstrate that pathological changes in DNA methylation homeostasis may underlie epileptogenesis and reversal of these epigenetic changes with adenosine augmentation therapy may halt disease progression.
UR - http://www.scopus.com/inward/record.url?scp=84879710932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879710932&partnerID=8YFLogxK
U2 - 10.1172/JCI65636
DO - 10.1172/JCI65636
M3 - Article
C2 - 23863710
AN - SCOPUS:84879710932
SN - 0021-9738
VL - 123
SP - 3552
EP - 3563
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 8
ER -